How M2M Will Accelerate Clinical Research

By Derk Arts

Machine-to-machine focuses on leveraging devices connected directly to the Internet of Things. Outside of the life sciences industry, other sectors, such as energy and transportation, have adopted the technology with strict regulatory requirements.

Big pharma companies are turning this capability into a competitive advantage by streaming data in real-time into their drug discovery platforms. Meanwhile, in clinical research, there’s academic interest in using M2M technology to help cure rare diseases with little data. In this article, the author describes their personal interest in creating a future where researchers can co-create and access the most extensive, diverse, and distributed medical research dataset the world has ever seen.

Discover how M2M can make it possible.